In the current contribution, we extracted and analysed cannabis indicator data from publicly available sources, including prevalence of use, prevalence of cannabis use disorder (CUD), treatment rates, and potency of cannabis products in Europe. We aimed to describe the trends of these indicators for the period 2010 to 2019 and the possible public health implications. Further, we aimed to highlight limitations in the available data, in order to identify the steps required to improve current practice in monitoring of cannabis use and harm in Europe.
